mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.0068 |
0.9 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |